Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal

NEW YORK (AP) — Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.